Collaboration/cooperation with external institutions Global Alliance for Chronic Diseases
Global Alliance for Chronic Diseases
As of January 2017, GACD membership is composed of 13 major funding agencies from 13 countries, including AMED, which joined the organization in June 2016.
Recently, the policy targets set by the GACD tend to be reflected in the policies of the World Health Organization (WHO). In addition, as pointed out in Japan's healthcare and medical strategies, rapid population aging is observed not only in Japan but also in Asian countries. Therefore it is expected to be of great benefit for AMED to monitor global discussions and trends and proactively participate in global collaborative research through the GACD, which, in turn, will contribute greatly to the development of medicine in Japan.
Each research project under the GACD programs is funded not by the GACD, but by its respective member agencies.
AMED's participation in the GACD
AMED officially joined the GACD at the Board meeting held in Tokyo in June 2016, with Dr. Makoto Suematsu, President of AMED, and Dr. Reiko Akizuki, Director of the AMED London Office, assuming the positions of Board member and Management Committee member, respectively.
The GACD Board hosts two meetings (June and December) and two teleconferences (March and September) each year. Board members participate in other committees and workshops so as to stay current with the latest information. The Management Committee hosts regular annual meetings as well as irregular meetings in line with the progress of projects. Through these meetings, hot topics around chronic non-communicable diseases, updates on ongoing discussions on agenda items, and their solution strategies can be analyzed. The outcomes are shared across AMED to facilitate networking among researchers in Japan and other countries, thereby promoting global collaborations.
AMED's participation in an international joint call for research proposals
Last updated 04/05/17